دورية أكاديمية

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

التفاصيل البيبلوغرافية
العنوان: Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
المؤلفون: Moreau, Philippe, Chari, Ajai, Oriol, Albert, Martinez-Lopez, Joaquin, Haenel, Mathias, Touzeau, Cyrille, Ailawadhi, Sikander, Besemer, Britta, de la Rubia Comos, Javier, Encinas, Cristina, Mateos, Maria-Victoria, Salwender, Hans, Rodriguez-Otero, Paula, Hulin, Cyrille, Karlin, Lionel, Sureda Balari, Anna, Bargay, Joan, Benboubker, Lotfi, Rosiñol, Laura, Tarantolo, Stefano, Terebelo, Howard, Yang, Shiyi, Wang, Jianping, Nnane, Ivo, Qi, Ming, Kosh, Michele, Delioukina, Maria, Goldschmidt, Hartmut
المساهمون: Janssen Research and Development
المصدر: Blood Cancer Journal ; volume 13, issue 1 ; ISSN 2044-5385
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2023
مصطلحات موضوعية: Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41408-023-00805-x
الإتاحة: https://doi.org/10.1038/s41408-023-00805-xTest
https://www.nature.com/articles/s41408-023-00805-x.pdfTest
https://www.nature.com/articles/s41408-023-00805-xTest
حقوق: https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test
رقم الانضمام: edsbas.1F82BCDA
قاعدة البيانات: BASE